Patents
Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726)
10/2004
10/28/2004CA2522205A1 Process for preparing macrocyclic compounds
10/28/2004CA2521831A1 Benzoxepino-11-piperidylidene compounds and process for production thereof
10/28/2004CA2521810A1 Substituted quinobenzoxazine analogs
10/28/2004CA2521364A1 [c]-fused bicyclic proline derivatives and their use for treating arthritic conditions
10/27/2004EP1471068A1 Process for total synthesis of ecteinascidins and intermediates therefor
10/27/2004EP1470129A2 Radiolabeled neuropeptide y y5 receptor antagonists
10/27/2004EP1470128A1 Intermediates for preparing glycogen phosphorylase inhibitors
10/27/2004EP1470126A1 N-substituted spiropiperidine compounds as ligands for orl-1 receptor
10/27/2004EP1470125A1 Aminopiperidine derivatives
10/27/2004EP1469854A1 Condensed heterocyclic compounds
10/27/2004EP1469809A2 Multiple acting anti-angiogenic and cytotoxic compounds and methods for using the same
10/27/2004EP0960108B1 Matrix metalloproteinase inhibitors
10/27/2004EP0858996B1 Nerve cell protective agents
10/27/2004CN1541219A Tricyclic imidazopyridines
10/27/2004CN1541214A Novel compounds
10/27/2004CN1172935C High-efficient production method for 10-hydroxycamptothecine
10/27/2004CN1172917C Steroid receptor modulator compounds and methods
10/26/2004US6809202 Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof
10/26/2004US6809105 Diazabicyclic central nervous system active agents
10/26/2004US6809103 E-ring expanded camptothecin derivatives
10/26/2004US6809092 1,3,4,5-tetrahydro-2h-2-benzazepin-2-yl derivatives; cysteine protease inhibitors
10/21/2004WO2004089949A1 7-([1,4]dioxan-2-yl)-benzothiazole derivatives as adenosine receptor ligands
10/21/2004WO2004089939A1 Condensed furan derivatives as adenosine antagonists
10/21/2004WO2004089931A1 Substituted pyrazoles
10/21/2004WO2004089926A2 Genipin derivatives and uses thereof
10/21/2004WO2004089307A2 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
10/21/2004WO2004058144A3 Antibacterial agents
10/21/2004WO2003062241A8 Fused heterocyclic succinimidecompounds and analogs thereof, modulators of nuclear hormone receptor function
10/21/2004US20040209934 Protein phosphate inhibitors
10/21/2004US20040209874 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-alpha converting enzyme (TACE)
10/21/2004US20040209871 Fused bicyclic nitrogen-containing heterocycles
10/21/2004US20040209864 Substituted heterocycle fused gamma-carbolines
10/21/2004US20040209846 Heterocyclic analgesic compounds and methods of use thereof
10/21/2004CA2521201A1 Substituted pyrazoles for use in the prophylaxis or treatment of a disease which can be influenced by the binding of the substitued pyrazoles to 5ht receptors
10/21/2004CA2520114A1 Acylated spiropiperidine derivatives as melanocortin-4 receptor agonists
10/20/2004EP1467997A1 Pyrrolopyrimidine and pyrrolopyridine derivatives substituted with cyclic amino group
10/20/2004EP1467993A1 Method for producing scopine esters
10/20/2004EP1467979A2 FUSED HETEROCYCLIC COMPOUNDS AND ANALOGS THEREOF: MODULATORS OF NUCLEAR HORMONE RECEPTOR FUNCTION
10/20/2004EP1467975A1 Substituted alkyl uracils and the use thereof
10/20/2004EP1467723A1 Phenyl sulfoxides and phenyl sulfones
10/20/2004EP1206473B1 Isomeric fused pyrrolocarbazoles and isoindolones
10/20/2004CN1538956A Spiro compounds
10/20/2004CN1538846A Oral administration of 6-hydroxy-oxymorphone for use as antalgesic
10/20/2004CN1171893C Microencapsulated lewis acid
10/20/2004CN1171887C Respiratory syncytial virus replication inhibitors
10/20/2004CN1171871C 1-alkoxy-polyalkyl-piperidine derivatives and their use as polymerization regulators
10/19/2004US6806312 Thermoplastic resin composition
10/19/2004US6806288 Cyclooxygenase-2 mediated disorders; reduces inflammation; fewer side effects
10/19/2004US6806283 Selective serotonin receptor antagonists and therapeutic applications thereof
10/19/2004US6806264 Arylphenyl-substituted cyclic ketoenols
10/19/2004CA2296901C Piperidine derivates having anxiolytic effect
10/14/2004WO2004087715A1 Process for preparing topotecan from 10-hydroxy-4-(s) camptothecin
10/14/2004WO2004087701A1 Cyclic benzimidazoles
10/14/2004WO2004087145A2 Antibacterial agents
10/14/2004WO2004087056A2 BI-CYCLIC PYRIMIDINE INHIBITORS OF TGFβ
10/14/2004WO2004078116A3 P38 inhibitors and methods of use thereof
10/14/2004US20040204584 Alzheimer's disease; Parkinson's disease; antidepressants
10/14/2004US20040204421 Certain 1,3-disubstituted isoquinoline derivatives
10/14/2004US20040204397 Calcitonin gene related peptide receptor antagonists
10/14/2004US20040204347 administering an effective amount of an inhibitor of the interaction of glutamate with the alpha -amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptor complex to treat demyelinating disorders
10/14/2004US20040204317 fluorescein dyes that exhibit a first color when in the crystal structured form and a second color when in the liquid, amorphous form, for use in thermal printing
10/14/2004US20040200388 Perylene-derivative based crystallization modifiers
10/14/2004DE10315572A1 Substituierte Pyrazole Substituted pyrazoles
10/14/2004CA2520581A1 Cyclic benzimidazoles
10/14/2004CA2520465A1 Bi-cyclic pyrimidine inhibitors of tgf.beta.
10/13/2004EP1465900A1 Rho-kinase inhibitors
10/13/2004EP1465896A2 Mitotic kinesin inhibitors
10/13/2004EP1465895A2 4-oxo-4,7-dihydrofuro(2,3-b)pyridine-5-carboxamide antiviral agents
10/13/2004EP1465889A1 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
10/13/2004EP1465630A1 Cyclic urea derivatives with 5-ht2c receptor activity
10/13/2004EP1465625A2 Solubilized topoisomerase poisons
10/13/2004EP1397137A4 Hydantion derivatives as inhibitors of matrix metalloproteinases
10/13/2004EP1381615B1 ANTIDEPRESSANT INDOLETETRAHYDROPYRIDINE DERIVATIVES OF 2,3-DIHYDRO-7H- [1,4]DIOXINO[2,3-e]INDOLE
10/13/2004EP1211253B1 Tricyclic dihydrobenzofuran derivatives, process for the preparation thereof and agents
10/13/2004EP1169038A4 Cyclic protein tyrosine kinase inhibitors
10/13/2004EP1086086B1 Imidazolyl derivatives and their use as somatostatin receptor ligands
10/13/2004CN1537016A Remedies for psychoneurosis
10/13/2004CN1535969A Total alkaloid of xiatianwu (a Chinese medicinal material), its preparation method and application
10/13/2004CN1535958A Alpha-substituted pyrimidine. thioalkyl and alkyl ether compound
10/13/2004CN1535956A Substituted phenyl keto-enol pesticide and weedicide
10/13/2004CN1535682A Medicine for improved bladder excretion capacity
10/13/2004CN1170830C Prepn. of levo-ofloxacin
10/12/2004US6803471 Useful as photochromic compounds; covalently attached to wang resins and method of attaching; ophthalmic lenses
10/12/2004US6803372 Such as cis-n-(4-benzoylphenyl)-4-hydroxy-3'-oxospiro (cyclohexane-1,1' (3'h)-isobenzofuran)-4-carboxamide for use as neuropeptide y receptor antagonist for treatment bulimia, obesity or diabetes
10/12/2004US6803368 Antipsychotic aminomethyl derivatives of 7,8-dihydro-3H-6,9-dioxa-1,3-diaza-cyclopenta[a]naphthalene
10/12/2004US6803129 Organic light emitting diode and organic luminescent materials thereof
10/12/2004CA2387401C Compositions, methods and systems for the production of enediynes
10/07/2004WO2004085440A1 Benzofuro-1,4-diazepin-2-one derivatives
10/07/2004WO2004085428A1 A new process for preparing olmesartan medoxomil
10/07/2004WO2004085382A1 Compound inhibiting in vivo phosphorus transport and medicine containing the same
10/07/2004WO2004084901A1 Methods for treating or preventing an inflammatory or metabolic condition by inhibiting jnk
10/07/2004WO2004075823A3 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
10/07/2004WO2003068748A9 Novel pyridine- and quinoline-derivatives
10/07/2004US20040198981 Tricyclic dihydroquinoline derivatives,method for preparing same and pharmaceutical compositions containing same
10/07/2004US20040198980 Selective rxr ligands
10/07/2004US20040198808 Halogenated triptolide derivatives as immunomodulators and anticancer agents
10/07/2004US20040198791 Fused imidazole derivative
10/07/2004US20040198764 Prodrugs of imidazopyridine derivatives
10/07/2004US20040198760 Anticancer agents ; skins, prostate glands, lungs, breasts, leukemia, central nervous system, colon
10/07/2004US20040198759 Aporphine and oxoaporphine compounds and pharmaceutical use thereof